SR biotek

270210 · KONEX · ₩270210 · 에스알바이오텍

₩9,350▼ ₩50 (0.53%)End-of-day · Oct 30, 2026 · End-of-day prices.
Trade
Alert me
Price · 1Y −41.16%
Market cap
₩16B
Enterprise value
—
P/E
—
P/B
—
Dividend yield
0.0%
ROE
—
Net margin
—

Financial statements not available yet. Dividend yield: the 2025 dividend per share from the annual report ÷ today's price.

52-week range−72.5% from the high

₩8,010Today: ₩9,000 – ₩9,380₩33,950

Returns

  • 1W−4.6%
  • 1M−21.9%
  • 3M−24.2%
  • 6M−48.7%
  • YTD−56.8%
  • 1Y−41.2%
Volume today
40
0.1× the 20-day average
Traded today
₩370,270
Listed shares
1,711,448
EPS (12 months)
—
AI researchResearch not started yetResearch starts once this company's financial statements are available.

🎁 Gift this stock

Send a friend ₩100,000 of paper money in this stock. They get it when they join.

Signals

27Quiet
  • BuzzQuietBuzz 27 of 100 (50 is a normal day for this stock).
  • MomentumWeak-22.1% over the last month; the price is below its 20-day average.

Signals describe activity, not recommendations. Not financial advice.

SR biotek stock overview

SR biotek (에스알바이오텍, KRX: 270210) is listed on KONEX, in the Cosmetics sector. This section describes the South Korean cosmetics industry, covering products such as basic skincare, makeup, body cleansers and hair care, along with the contract manufacturing (ODM and OEM) segment, where large companies hold a significant share of the market. Its shares closed at ₩9,350 on Oct 30, 2026, down 0.53% on the day, giving it a market value of ₩16B.

Key facts

Market cap
₩16B
Sector
Cosmetics
Latest price change
−0.53%
As of
Oct 30, 2026
Main business
This section describes the South Korean cosmetics industry, covering products such as basic skincare, makeup, body cleansers and hair care, along with the contract manufacturing (ODM and OEM) segment, where large companies hold a significant share of the market.

Quick answers about SR biotek

What does SR biotek do?
This section describes the South Korean cosmetics industry, covering products such as basic skincare, makeup, body cleansers and hair care, along with the contract manufacturing (ODM and OEM) segment, where large companies hold a significant share of the market. It also notes that Korean cosmetics exports have grown over recent years, and that the industry faces tightening regulations in major overseas markets.
What is the market cap of SR biotek?
The market capitalisation of SR biotek was ₩16B at the close on Oct 30, 2026.
Who are the largest shareholders of SR biotek?
According to the latest official filings, the largest reported holders are Lee So-hyung (52.48%, as of Feb 13, 2026); Kim Ah-ri (0.47%, as of Aug 4, 2025).
When is the next earnings report from SR biotek?
Korean companies rarely announce results dates in advance. Based on when SR biotek filed the same report in past years, its next annual results is expected between Mar 16, 2027 and Mar 20, 2027.

Company profile

This section describes the South Korean cosmetics industry, covering products such as basic skincare, makeup, body cleansers and hair care, along with the contract manufacturing (ODM and OEM) segment, where large companies hold a significant share of the market. It also notes that Korean cosmetics exports have grown over recent years, and that the industry faces tightening regulations in major overseas markets.

Written by AI from the company's latest annual report.

Korean name
에스알바이오텍
Sector
Cosmetics
Themes
K-beauty
CEO
이소형
Founded
May 2007
Listed
Jun 2017
Listed shares
1,711,448
Fiscal year ends
Month 12

Similar companies

Recent filings

See all

Titles in Korean until English translations are added.

Also known as: SR biotek / 에스알바이오텍 / 270210 / KRX:270210

Source: KRX statistical information